Overview

Saline Hypertonic in Preschoolers

Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks improves the lung clearance index by multiple breath nitrogen washout in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 5) with cystic fibrosis.
Phase:
N/A
Details
Lead Sponsor:
University of Washington, the Collaborative Health Studies Coordinating Center
Collaborators:
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Therapeutics